T2 Biosystems Inc Valor Contábil/Ação
Qual é o Valor Contábil/Ação de T2 Biosystems Inc?
O Valor Contábil/Ação de T2 Biosystems Inc é -6.20
Qual é a definição de Valor Contábil/Ação?
O valor contábil por ação é um ativo da empresa menos as responsabilidades dividido pelo número de ações em circulação.
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
Valor Contábil/Ação de empresas na Setor Health Care em NASDAQ em comparação com T2 Biosystems Inc
O que T2 Biosystems Inc faz?
t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www
Empresas com valor contábil/ação semelhantes a T2 Biosystems Inc
- Novavax tem Valor Contábil/Ação de -6.51
- American Airlines Inc tem Valor Contábil/Ação de -6.46
- Vector Ltd tem Valor Contábil/Ação de -6.37
- Dine Brands Global Inc tem Valor Contábil/Ação de -6.36
- Mettler-Toledo International tem Valor Contábil/Ação de -6.33
- Harte Hanks tem Valor Contábil/Ação de -6.26
- T2 Biosystems Inc tem Valor Contábil/Ação de -6.20
- i-nexus Global plc tem Valor Contábil/Ação de -6.20
- Lowe's Companies tem Valor Contábil/Ação de -6.17
- Wyndham Destinations Inc tem Valor Contábil/Ação de -6.17
- Quantum Corp tem Valor Contábil/Ação de -6.15
- Simbhaoli Sugars tem Valor Contábil/Ação de -6.12
- Bridgemarq Real Estate Services tem Valor Contábil/Ação de -6.08